[The use of myolastan in athletes with myoenthetic injuries].
Myolastan was given to 9 sportsmen with acute muscular injury and 5 with chronic one in addition to the standard treatment. Control subjects with similar acute and chronic injuries (7 and 3 patients, respectively) were not given the drug. The patients with acute injuries on myolastan resumed muscular exercise 4.5 weeks after the trauma, while similar controls were able to do that only 6 weeks after it. Chronic injury patients returned to their routine loads 1 week earlier than controls. Myolastan proved effective in combined treatment of acute and chronic myoenthetic damage.
Mironov
S P
SP
Burmakova
G M
GM
Fedotova
T M
TM
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents; D001265:Athletic Injuries / Q000188:drug therapy*; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000627:therapeutic use*; D009132:Muscles / Q000293:injuries*
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D009125:Muscle Relaxants, Central; D001569:Benzodiazepines; C005245:tetrazepam
Primeneie miolastana u sportsmenov s povrezhdeniiami mioéntezicheskogo apparata.